Project Grant R21AG085324
Award Date
9/16/23
Completion Date
9/15/25
Dollars Obligated
$424K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Rochester, NY 14642, USA
Similar Awards
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research into the role of mitochondrial deficits in tauopathy-linked autophagy defects. The total funding amount is $431,750.00 and the award period runs from June 1, 2025 to May 31, 2027. The primary objective is to determine the mechanism by which overexpression of the mitochondrial protein MIRO enhances autophagy and alleviates tau pathology in tauopathy neurons. Specifically, the...
The National Institute on Aging (NIA) awarded a $763,922 Project Grant under the Aging Research federal grant program (CFDA 93.866) to The Leland Stanford Junior University. The 5-year grant, with a start date of June 1, 2025 and an end date of April 30, 2030, will fund research to investigate the mechanism by which abnormal tau protein interacts with mitochondrial dysfunction and contributes to the development of age-related neurodegenerative diseases like Alzheimer's, Parkinson's, and...
This federal Project Grant award of $1,118,700.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) to New York University School of Medicine will support research to elucidate the role of pathological tau protein in disrupting endosomal microautophagy (EMI), a critical protein degradation pathway affected in Alzheimer's disease. The research aims to determine which components of the EMI pathway are most vulnerable to tau pathology and whether restoring EMI function can...
This $717,709 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to Weill Medical College of Cornell University aims to discover Alzheimer's disease (AD)-relevant cellular mechanisms underlying the propagation of misfolded tau aggregates in human neurons. The research will utilize advanced proteomic techniques, including affinity purification mass spectrometry and transcriptomics, in combination with newly generated knockin human induced pluripotent stem cell...
This Project Grant award from the National Institute on Aging, under the Aging Research federal grant program (CFDA 93.866), provides $308,000.00 to the Regents of the University of Minnesota to investigate the impact of amyloid-beta 42 (Aβ42) on mitochondrial ribonucleoprotein granule dynamics and utilize optogenetic control of Aβ42 and mitochondrial ribonucleoprotein granules in mitochondria. The overarching goal is to identify the mechanisms by which Aβ42 interferes with mitochondrial...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research into the role of local protein synthesis in the development of tau pathology and neurodegeneration associated with Alzheimer's disease. The $1,147,300 grant awarded to Wayne State University will fund a 5-year project to investigate how pathogenic forms of the tau protein interfere with dendritic protein synthesis, which may contribute to the early synaptic dysfunction seen in...
This federal Project Grant award of $2,895,962 from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to investigate how a microRNA, miR-129-2, may protect against tau accumulation and neurodegeneration in Alzheimer's disease. The project, conducted by Trustees of Boston University, aims to map the expression of miR-129-2 in the entorhinal cortex across mouse and human samples, examine how miR-129-2 regulates Alzheimer's disease-relevant genes and pathways,...
The National Institute on Aging (NIA) awarded a $773,816 Project Grant (CFDA 93.866 - Aging Research) to the University of California, Irvine to conduct a comprehensive study on the molecular mechanisms underlying aberrant protein accumulation in Alzheimer's disease-related tauopathies. The project aims to generate cell-type-specific atlases of misprocessed RNAs and proteins in mouse models and human brain tissues to identify new pathways and protein interaction networks involved in...
This $1,592,854 project grant was awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Illinois to investigate the molecular mechanisms underlying tau protein dysfunction in neurodegenerative tauopathies, including Alzheimer's disease and related dementias. The overarching goal is to understand how disease-related changes in tau conformation and post-translational modifications disrupt tau's normal scaffolding functions and lead to dysregulation of key...
This $1,100,000 Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) supports research by the University of Texas Medical Branch at Galveston (UTMB) to investigate the mechanisms of pathological tau protein spreading in Alzheimer's disease. The project aims to determine how amyloid-beta oligomers modulate the binding and internalization of toxic tau oligomers at synapses, which is a key component of the trans-synaptic spreading of tau...